Back to BARCLAYS PLC BARCLAYS PLC

VKTXVKTX

Showing 8 of 31 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in VIKING THERAPEUTICS INC

Yes. Barclays holds 52,991 shares of VKTX (Viking Therapeutics), worth $2.1M, as of its Q2 2026 13F filing. It reduced the position by 17,288 shares (-24.6%) from Q1 2026. Barclays has held VKTX in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$2.1M

Current Shares

52,991

Total Value Change

-$4.5M

Total Shares Change

-50,140

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
52,991
-24.6%
$2.1M0.0%$39.01
0
2026-Q1
Decreased
70,279
-86.4%
$2.3M0.0%$32.54
0
2025-Q4
Increased
516,656
+12.1%
$18.2M0.0%$35.18
32
2025-Q3
Increased
460,807
+99.3%
$12.1M0.0%$26.28
45
2025-Q2
Decreased
231,200
-48.1%
$6.1M0.0%$26.50
0
2025-Q1
Increased
445,695
+381.5%
$10.8M0.0%$24.15
45
2024-Q4
Decreased
92,556
-10.3%
$3.7M0.0%$40.24
0
2024-Q3
Increased
103,131
+15.6%
$6.5M0.0%$63.31
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used